Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 5/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL813355 | 0.74 | CA1 (0.43) | EPHX2HSD17B10L3MBTL1CA1CA2 | |
| SCHEMBL6154544 | 0.74 | EPHX2 (0.41) | EPHX2HSD17B10L3MBTL1CYP2C9CA1 | |
| SCHEMBL11148891 | 0.67 | EPHX2 (0.50) | EPHX2HSD17B10L3MBTL1CYP2C9CA1 | |
| SCHEMBL1072726 | 0.67 | EPHX2 (0.50) | EPHX2HSD17B10L3MBTL1CYP2C9CA1 | |
| Hydrochloric Acid SCHEMBL11156725 | 0.65 | EPHX2 (0.48) | EPHX2HSD17B10L3MBTL1CYP2C9CA1 | |
| SCHEMBL2297553 | 0.63 | EPHX2 (0.46) | EPHX2HSD17B10L3MBTL1CYP2C9CA1 | |
| SCHEMBL1502375 | 0.63 | CA1 (0.48) | EPHX2HSD17B10L3MBTL1CYP2C9CA1 | |
| SCHEMBL2604739 | 0.63 | EPHX2 (0.46) | EPHX2HSD17B10L3MBTL1CYP2C9CA1 | |
| SCHEMBL12408108 | 0.63 | EPHX2 (0.46) | EPHX2HSD17B10L3MBTL1CYP2C9CA1 | |
| SCHEMBL7672245 | 0.63 | EPHX2 (0.52) | EPHX2HSD17B10L3MBTL1CYP2C9CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1778637-B1 | FKBP-binding composition and pharmaceutical use thereof | AVENTIS PHARMA INC (US) | 2012-02-22 | — | — | EP | claimed |